We found that selective MYCN inhibition resulted in a significant reduction of blast cells viability ex vivo. An encouraging impairment of cell growth and viability, mainly through the activation of the apoptotic pathway, was also observed in T-ALL cell lines. The gene discussed is MYCN; the disease is acute lymphoblastic leukemia.